- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kiana Mehring Discusses the Future of Value-Based Oncology Care
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute, shares her thoughts on future directions in value-based oncology care and research.
Patient-reported outcomes are crucial to the future landscape of value-based oncology care and research models, says Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS).
Transcript
How do you see the future of value-based oncology care evolving, both within FCS and in the broader health care landscape?
One of the exciting things that value-based care has been moving toward in recent years is a patient-centric approach. The landscape is shifting to tailor treatments to individual patient needs, their preferences, outcomes, etc. Personalized medicine is certainly on the rise and patient engagement continues to be important.
I think another thing we're going to see in the coming years is more and more patient-reported outcomes. As we implement it into care models, that is really going to ensure that we're making our decisions, not without the patient included, but including the patient in the center of those decisions with the oncologist.
I also believe there's going to be a continued emphasis on early detection and preventative strategies that are going to reduce the need for those costly, late-stage treatments.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
